ASGN Inc. (ASGN) Misses Q4 EPS by 1c

ASGN Inc. (NYSE: ASGN) reported Q4 EPS of $1.14, $0.01 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $929.7 million versus the consensus estimate of $916.28 million.

GUIDANCE:

ASGN Inc. sees Q1 2019 EPS of $0.92-$0.99, versus the consensus of $0.99. ASGN Inc. sees Q1 2019 revenue of $916.6-926.6 million, versus the consensus of $899.4 million.

For earnings history and earnings-related data on ASGN Inc. (ASGN) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
• Ascendis Pharma (ASND) Tops Q2 EPS by 132c